Rationale: Sputum and bronchoalveolar lavage fluid (BALF) are often obtained to elucidate the lower airway microbiota in adults. Acquiring sputum samples from children is difficult and obtaining samples via bronchoscopy in children proves challenging due to the need for anesthesia and specialized procedural expertise; therefore nasopharyngeal (NP) swabs are often used as surrogates when investigating the pediatric airway microbiota. In adults, the airway microbiota differs significantly between NP and BALF samples however, minimal data exist in children.
prohibiting the collection of lower airway samples in both healthy children and those with lower respiratory disease unless ordered for clinical purposes. Given this, upper airway samples often serve as a surrogate of the lower airway.
In healthy adults, differences exist between the upper and lower airway microbiota. 1, 2 Overlap exists between the oral and lung microbiota while the nasal microbiota does not share bacterial communities with either location in healthy adults. 2 Differences between sampling location also exist in children and adults with cystic fibrosis. 3, 4 However, there are limited studies comparing the upper and lower airway in children without cystic fibrosis.
It was recently reported that upper airway sampling provided a reliable representation of BALF microbiota in children with protracted bronchial bronchitis and chronic suppurative lung disease with a combination of nasopharyngeal (NP) and oropharyngeal (OP) samples offering the best representation of the lower airway. 5 Because many studies examining upper airway diseases including early wheeze have focused on the NP microbiota, we focused on comparing the NP microbiota and BALF microbiota in all children regardless of the reason for their bronchoscopy. We hypothesized that the NP microbiota and BALF microbiota would differ in children regardless of their diagnosis.
To address this issue, we compared NP swabs and BALF samples from all children undergoing clinically indicated bronchoscopy to determine if NP swabs reflect the BALF microbiota.
2 | METHODS
| Participants
Inclusion criteria were children undergoing a clinically indicated bronchoscopy in the Riley Children's Hospital outpatient center (Indianapolis, IN). Children were excluded if parents and/or children refused to give informed consent. This study was approved by the Indiana University Human Subjects Committee. If the participant was <18 years of age, written informed consent was obtained from the parents and assent was obtained from children ≥11 years of age. If the patient was ≥18 years of age, full consent was obtained from the patient. After consent was obtained, a questionnaire was administered asking basic demographic questions (gender, race, and ethnicity).
NP swabs were obtained prior to bronchoscopy using Copan eSwab 482C in Amies Transport Medium (Copan Diagnostics, Murrieta, CA). Samples were obtained by rubbing the swab on the mid-inferior turbinate for 10 s, then placed in transport media (Amies fluid). Samples were then placed on ice while awaiting BALF collection.
Bronchoscopy was performed under general anesthesia following current American Thoracic Society (ATS) guidelines. 6 The bronchoscope was introduced via laryngeal mask airway (LMA) or trans-nasally.
Passage of the bronchoscope nasally was utilized when the clinician elected to evaluate the upper airway. If bronchoalveolar lavage was performed, any extra BALF available that exceeded the 10 mL of BALF necessary for clinically indicated studies was collected for this study.
BALF was placed in a sterile container, placed on ice with the corresponding NP swab, and taken to the laboratory (within the same building) where it was aliquoted and stored at −80°C until DNA extraction occurred. An average of 13 mL of BALF was collected during the procedure. After removing 10 mL for clinically indicated laboratory studies, there was an average of 3 mL remaining for this study.
| DNA extraction
Prior to extraction, 1 mL of BALF was centrifuged at 10 000g for 10 min. Sequencing was performed on an Illumina MiSeq. 8 The resulting sequence reads were de-multiplexed using CASAVA software installed on the MiSeq Illumina sequencer producing 6 042 668 sequencing reads. Separate pairs of fastq files were generated for each specimen.
The splicing of forward and reverse fastq files produced an average of 100 710 ± 48 567 reads per specimen.
| Sequence quality analysis
A 16S rRNA sequence processing was performed utilizing mothur (v.1.33.3) software 9,10 and adapted from their 16S MiSeq Protocol.
Raw paired-end fastq sequences were combined into contigs using make.contigs. Contigs were then aligned against release 123 of the SILVA 16S reference alignment using align.seqs, and contigs that did not match the V1-V3 regions were discarded. Sequencing error correction was performed with pre.cluster, allowing up to three bases to be corrected per read. We then used the UCHIME algorithm 11 from within mothur to detect and remove chimeric sequences. The classify.
seqs command and RDP training set were used to filter sequences identified as non-bacteria. 12 
| Operational taxonomic unit (OTU) clustering and classification
Remaining sequences were clustered using swarm with the fastidious parameter. 13, 14 Swarm is a single-linkage clustering tool that uses a local (rather than global) clustering threshold. Sequence abundance is used to delineate OTUs with high precision. The representative sequences for each OTU was classified using BLAST 15 against release 123 of the SILVA SSU database. 16 We applied an abundance filter, removing all OTUs that did not compose 2% or more of the read population of at least one sample. Due to concern for contamination, we extracted DNA from sterile water passed through the bronchoscope prior to utilization; the reagents; blank swabs; and sterile water.
Sequences detected in control samples clustered into 15 OTUs that constituted >80% of total sequence reads detected in negative controls (Supplemental Table S1 ). These OTUs were excluded from all subsequent analysis, and represented less than 1.5% abundance in participant samples.
| Sequence analysis
Rarefaction curves describing the number and proportionality of OTUs observed as a function of sampling effort were generated using alpha_rarefaction.py in QIIME (1.9.1). 17 Random sub-sampling to the smallest sample size (3935) was performed to address concerns of different sequencing depths across samples affecting the rarefaction curves. Shannon diversity and Chao 1 richness indices were calculated from the sub-sampled OTU abundance data using QIIME.
The align_seqs.py and make_phylogeny.py commands in QIIME were used to align OTU consensus sequences 18 and construct a taxonomic tree. 19 The weighted UniFrac and Bray-Curtis distances were calculated between participants and sample types for variation analysis using the beta diversity.py command in QIIME. Both methods are qualitative measures of community dissimilarity, however weighted UniFrac incorporates phylogenetic relatedness between OTUs. Principal coordinate analysis (PCoA), which employs an eigenvector-based approach, was performed with the QIIME suite to represent the multidimensional data of OTU abundance in three dimensions. OTU frequencies were compared across sample types and other groups at multiple taxonomic levels using the group_significance.py command from QIIME using Student's t-test.
The conservative Bonferroni method of multiple testing correction was followed, with each P-value being multiplied by the number of OTU/taxa tested.
| RESULTS
Thirty-six participants were approached and consented to participate in this study between January 2015 and March 2016.
One participant was also enrolled in the NIH funded observational Early Cystic Fibrosis study. Because the Early Cystic
Fibrosis study is an observational study, we determined that participating would not influence our results. Sequences were successfully measured from all 72 samples.
The 36 participants included in the study consisted of 18 males (50%); had a median age of 3.3 years (interquartile range 1.3-5.2 years) ( Table 1 ). The most common reason for bronchoscopy was chronic cough (61% of participants) followed by noisy breathing (14%) ( Table 2 ). The most common underlying diagnosis was recurrent bronchitis/pneumonia (67%) followed by asthma (61%) and gastroesophageal reflux (22%) ( Table 3) 
FIGURE 1
Mean diversity between BALF and NP samples utilizing Chao1 Richness index P = 0.001 (A), and Shannon diversity P = 0.001 (B) FIGURE 2 Weighted unifrac plot presents the multidimensional data of OTU abundance in three dimensions. It visually demonstrates that distinct clustering patterns were present between the two sampling methods. Red dots, BALF. Blue dots, NP swabs
FIGURE 3
Comparison of similarity between sample types. Microbiota detected in NP samples were more similar to their corresponding BALF (intra-subject comparison) compared to microbiota in BALF from other children (inter-subject comparison) (P = 0.001). Intra-subject NP and BALF microbiota was also more similar than NP samples between children (P = 0.02). Bray-Curtis dissimilarity is bounded between 0 and 1, so two samples with a distance of 1 would share no OTUs, where at 0 the samples would contain the same OTUs in the same proportionality The most abundant genera in the NP microbiota were Streptococcus (37.3%); Staphylococcus (14.6%); Haemophilus (10.1%); Corynebacteriaceae unknown genus (11.5%); Moraxella (7.7%);
Corynebacterium (5.3%); Propionibacterium (3.9%); Porphyromonas (1.4%); Neisseria (1.4%); Veillonella (1.3%); and Neisseriaceae unknown genus (1%). In the BALF, Streptococcus was also the most abundant genera (36.1%); followed by Neisseria (10.3%); Prevotella 7 (9.4%);
Alloprevotella (8.5%); Porphyromonas (7.3%); Staphylococcus (4%);
Veillonella (3.8%); Prevotella (2.9%); Fusobacterium (2.5%); Haemophilus (1.7%); Propionibacterium (1.5%); Granulicatella (1.4%); Mycoplasma (1.4%); and Gemella (1%). All other classified OTUs belong to genera compromising less than 1% of the total abundance.
To further explore the differences between upper and lower airway microbiota, we compared the relative abundance of BALF and NP samples using the Kruskal-Wallis nonparametric test and found significant differences at the phyla level. While BALF samples had more Bacteroidetes (29.5% vs 3.2%; adjusted P = 1.2 × 10 −9 ), NP samples had more Actinobacteria (2.2% vs 21%; adjusted P = 1.4 × 10 −6 ) ( Figure 5 ).
Further classification of the NP samples revealed higher abundance of bacteria within two genera of the Family Corynebacteriaceae. These include an unclassified genera (NP 11.5% vs 0.04%; adjusted P = 8.9 × 10 
| DISCUSSION
When comparing the microbiota between BALF and NP samples in children undergoing clinically indicated bronchoscopy, NP swabs reflected BALF within an individual. However, when samples were grouped based on type (NP vs BALF), differences were noted. These differences were likely due to averaging the relative abundance of multiple samples and suggests that caution should be made when making conclusions utilizing this method. Because intra-sample similarity was greater than inter-sample similarity, it is likely that differences will be detected between individuals regardless of the type of sampling method utilized.
Describing a "normal" lung microbiota in children is difficult due to our inability to perform bronchoscopy on healthy children. Previous studies have utilized upper airway samples as a surrogate of lower airway samples. However, adult studies comparing upper and lower airway microbiota demonstrate differences between the two, 1, 2, 20 suggesting that upper airway samples do not represent the lower airway microbiota. Due to ethical concerns surrounding the collection of lower airway samples in healthy "normal" children, samples were collected from children undergoing clinically indicated outpatient bronchoscopy ( Table 2) . While similar bacteria were found in both the upper and lower airway, other bacteria were only reported in one location. One such bacteria, Prevotella, was significantly more abundant in BALF than in NP samples. Similar findings have been reported in adult microbiota studies that examined oral swabs, BALF, and gastric fluid, 2 suggesting that other locations (mouth, GI tract) may contribute to the microbial make-up of the lower airway. Furthermore, in children with cystic fibrosis, the relative abundance of Pseudomonas FIGURE 6 Bacterial Abundance of 15 most common OTUs. *adjusted P < 0.001; **adjusted P < 0.01; †adjusted P < 0.05
and Staphylococcus was higher in the lower airway compared to the upper airway, further suggesting that NP samples are not always good surrogates for the lower airway microbiota. 3, 21 It was recently demonstrated that within young children with airway disease, combining OP and NP samples reflected BALF samples better than utilizing only OP or NP samples alone. 5 It may be possible that if we had analyzed OP swabs as well, we would have seen Prevotella in higher quantities in the upper airway. Future studies have been planned to utilize both methods of upper airway sampling in our pediatric studies.
In our pediatric participants, the most common genera in both A limitation of this study may be an insufficient number of samples to measure significant differences in community structure, and differences based on age. Because power calculations for microbiota analysis have not been standardized, determining the number needed to reach significance can be challenging. . We divided samples into quartiles based on age in an attempt to examine if age impacted richness, diversity, and/or changes in relative abundance but we did not find significant differences. A larger sample size would help further define and verify individual communities of bacteria across the various age groups thereby determining if borderline significant data is actually significant. While we attempted to standardize our sampling methods as much as possible, the procedures were clinically indicated; therefore, the route used to introduce the bronchoscope (laryngeal mask airway (LMA) or nasal) and which lung lobes to sample were selected by the performing physician. However, we collected the NP sample prior to bronchoscopy to limit possible contamination of lower airway bacteria on the upper airway during scope removal. Also, during analysis we compared BALF samples obtained via laryngeal mask airway (LMA) versus nasal entry and did not find a difference, suggesting that the route of entry did not impact sample analysis.
Because we could not control which lobe(s) were sampled, BALF may only represent the area(s) of the lung sampled and not the entire lung.
Our finding that diversity is greater in BALF than NP samples was previously reported in children with cystic fibrosis 3 . It is possible that the bacterial load differs between these two sampling methods thereby resulting in differences in diversity. Due to low sample volume, we were unable to perform qPCR on our samples to determine overall bacterial load. Future studies will focus on measuring bacterial load.
Contaminating DNA can be a challenge in samples with low microbial biomass, 22 therefore we extracted DNA from controls and excluded
OTUs detected in our negative controls (Supplemental Table S1 ) to prevent reporting bacterial contaminants.
In summary, we have performed a comparison of NP swabs and BALF in a pediatric population undergoing clinically indicated bronchoscopies. We report that the pediatric NP airway microbiota is similar to BALF samples for an individual but often have significantly different relative abundance of bacteria. Studies utilizing NP samples as surrogates for the lower airway, should be interpreted with caution.
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